Midilab RC
Midilab RC is Diosna’s modular laboratory equipment that offers a fluid bed and a tablet coater module for a flexible production. Different batch sizes and a rapid change between the modules are just some of the benefits.
The Midilab RC is Diosna’s modular laboratory equipment that offers a fluid bed and a tablet coater module. With the Midilab RC the company presents at Achema fair a solution for a flexible production, which is one of the focal topics of Achema 2018. Different batch sizes, rapid change between the modules without tools and flexible installation are just some of the benefits. Along with the flexible production, the focus is also on convenient operation. A swivelling and tilting operator terminal with stainless steel housing allows a flexible adjustment for the operator. Each module as well as the basic unit are moveable and fitting trough standardized doors. Furthermore, the air control and regulation technologies are located in the housing of the base unit. The front side is designed as a work bench to provide suspensions.
The picture is completed by the variety of processes. While sugar and film coating can be done in the three different drums of the coater module, the fluid bed module enable efficient granulation and coating via top-, tangential- or bottom spray in four different product bowls.
Contact Details:
Company name: Diosna Dierks & Söhne GmbHWebsite: www.diosna.comE-mail: info@diosna.de
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
